PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Editor´s Pick

Editor´s Pick

kENUP Foundation: Vaccine Skepticism in Germany Multiplies With Novel COVID Vaccines

KALKARA, Malta & BERN, Switzerland & LUXEMBOURG--(BUSINESS WIRE)--The first representative study of COVID-19 vaccine skeptics, conducted by kENUP Foundation, the Swiss Academies of Arts...
Admin - 0
Read more
Editor´s Pick

AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Receives FDA Emergency Use Authorization for COVID-19

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly...
Admin - 0
Read more
Editor´s Pick

i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-based Medicines

BOSTON--(BUSINESS WIRE)--i2O Therapeutics, developers of a platform for oral delivery of traditionally injectable biological drugs, announced today a research collaboration with Sanofi to investigate...
Admin - 0
Read more
Editor´s Pick

Moderna Announces COVID-19 Vaccine Supply Agreements with the Government of Taiwan for 5 Million Doses and the Government of Colombia for 10 Million Doses

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two supply agreements for the COVID-19...
Admin - 0
Read more
Editor´s Pick

What Do Doctors Want in 2021? Sixth Annual Predictions Report from Apollo Intelligence Shows Rising Need for Increased Drug Discovery, Along with Lower Drug...

WATERTOWN, Mass.--(BUSINESS WIRE)--Now in its sixth year, a report on physicians’ predictions for the coming year shows an elevated interest in drug discovery as...
Admin - 0
Read more
Editor´s Pick

Singapore Health Sciences Authority (HSA) Approves Interim Authorization of COVID-19 Vaccine Moderna For Use

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Singapore Health Sciences Authority (HSA)...
Admin - 0
Read more
1234...42Page 3 of 42

Recent Articles

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics

Industry News

BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan

Industry News

SYLVANT® (siltuximab) Recommended by the National Comprehensive Cancer Network® (NCCN®) as the Preferred Treatment Option for Patients with Idiopathic Multicentric Castleman Disease (iMCD) regardless...

Industry News

Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies

Industry News

Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty...

Look Who’s On the Move!

Merck Animal Health Completes Acquisition of Poultry Sense Limited

Industry News

Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited

Industry News

Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell...

Regulatory Affairs

New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19

Industry News

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell...

Regulatory Affairs

Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) as a First-Line Treatment for Patients with Advanced Renal...

Regulatory Affairs

EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

Regulatory Affairs

Ipsen Receives Positive CHMP Opinion Recommending Cabometyx® in Combination With Opdivo® as First-line Treatment for Patients Living With Advanced Renal Cell Carcinoma

Look Who’s On the Move!

European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older

Regulatory Affairs

Talaris Therapeutics Appoints Four Vice Presidents in Areas of Strategic Importance

Look Who’s On the Move!

2020 © Copyright - TPMG